Loading live market data…

Amylyx Pharmaceuticals, Inc.

NASDAQ:AMLX

$18.2 USD

$0.79 (4.54%)

Volume
2.02M
Average Volume
1.35M
Market Capitalization
$1.51B
P/E Ratio
-12.30
Dividend Yield
0.00%
Price Target
$34.00
Year High
$19.15
Year Low
$7.48
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$17.85

CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE

0.02%

Investors Holding

6

change: -175 | last: 181

Increased Positions

4

change: -87 | last: 91

Reduced Positions

0

change: -54 | last: 54

New Positions

0

change: -27 | last: 27

Sold Positions

166

change: 130 | last: 36

Total Calls

-

Total Puts

-

Put-Call Ratio

0.00

change: -20.8362 | last: 0.2084

Total Invested

404.32K

AMLX Enterprise Value History

Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $12.08 94.57M $1.14B $226.65M $5.96M $921.66M
2024-12-31 $3.78 68.14M $257.58M $77.39M $1.98M $182.17M
2023-12-31 $14.72 67.23M $989.69M $170.2M $4.24M $823.73M
2022-12-31 $36.95 66.51M $2.46B $62.53M $6.28M $2.4B
2021-12-31 $18.07 57.86M $1.05B $50.19M $- $995.41M
2020-12-31 $18.07 56.47M $1.02B $12.88M $1.42M $1.01B
2019-12-31 $18.07 56.47M $1.02B $3.06M $14.93M $1.03B
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-03-31 $13.90 110.56M $1.54B $229.14M $5.63M $1.31B
2025-12-31 $12.08 94.57M $1.14B $226.65M $5.96M $921.66M
2025-09-30 $13.59 93.33M $1.27B $225.18M $5.94M $1.05B
2025-06-30 $6.41 89.14M $571.38M $58.08M $5.96M $519.26M
2025-03-31 $3.54 85.7M $303.37M $59.76M $1.38M $244.99M
2024-12-31 $3.78 68.59M $259.28M $77.39M $1.98M $183.87M
2024-09-30 $3.24 68.09M $220.62M $71.84M $2.57M $151.34M
2024-06-30 $1.88 68.02M $127.89M $75M $3.14M $56.03M
2024-03-31 $2.71 67.85M $183.89M $170.55M $3.69M $17.03M
2023-12-31 $14.72 67.41M $992.34M $170.2M $4.24M $826.38M
2023-09-30 $18.31 67.41M $1.23B $135.26M $4.77M $1.1B
2023-06-30 $21.57 67.23M $1.45B $247.76M $5.29M $1.21B